Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
3(27%)

Phase Distribution

Ph not_applicable
10
91%
Ph phase_2
1
9%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

44.4%

4 of 9 finished

Non-Completion Rate

55.6%

5 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(4)
Terminated(5)
Other(1)

Detailed Status

Completed4
Terminated3
Withdrawn2
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
57.1%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (9.1%)
N/A10 (90.9%)

Trials by Status

terminated327%
unknown19%
withdrawn218%
completed436%
not_yet_recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11